Evidence map›Paper›PMID 41524897›Full record

ArticleClinical and experimental medicine2026

ViMDT: a clinical data visual analysis tool for multi-disciplinary treatment of lung cancer.

Weiwei Zhu, Xiaodong Jiang, Lei Zhang, Peng Zhou, Xinping Xie, Hongqiang Wang

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weiwei ZhuUniversity of Science and Technology of China, Hefei, 230026, Anhui, China.
Xiaodong JiangMedical Oncology Department, The First Affiliated Hospital of University of Science and Technology of China, Hefei, 230001, Anhui, China.
Lei ZhangDivision of Life Sciences and Medicine, Department of Pharmacy, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Peng ZhouSchool of Life Science, Hefei Normal University, Hefei, 230601, Anhui, China.
Xinping XieSchool of Mathematics and Physics, Anhui Jianzhu University, Hefei, 230031, Anhui, China.
Hongqiang WangInstitute of Intelligent Machines/Zhongqi AI joint Lab, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, China. hqwang126@126.com.

Funding

Anhui Clinical Medical Research Transformation Special Project 202304295107020050Anhui Province's key Research and Development Project 201904a07020092Anhui Provincial Natural Science Foundation 2022AH050247Laboratory of Operations Research and Data Science of Anhui Jianzhu University YCSJ2024ZR02National Natural Science Foundation of China 52373160National Natural Science Foundation of China 61973295Natural Science Foundation of Higher Education in Anhui Province 2024AH051569Research Initiation Fund Project of Introduced High-level Talents 60423018University Science Research Project of the Education Department of Anhui Province KJ2021A0633
6 · The paper itself

Abstract

Multi-disciplinary treatment (MDT) has become a routine practice in clinical cancer diagnosis and treatment, playing an indispensable role in clinical decision-making. By integrating expertise from multiple disciplines, MDT provides patients with individualized diagnosis and treatment strategies. However, there is not yet a specialized clinical data visualization tool for MDT. This paper develops a novel clinical data analysis visualization tool for MDT, which analyzes in-depth and displays patient data comprehensively. Specifically, this tool designs a latent Dirichlet allocation (LDA)-based visualization model for clinical unstructured data, and Z-Score-3σ transformation and hierarchical strategies for clinical structural data. Moreover, we propose to predict personalized anti-tumor drug efficacy based on topic keywords. The results showed that, compared with users who did not use the tool, the time cost in MDT decision-making for users who used the tool was reduced by 26.17%. Furthermore, the proposed drug efficacy prediction method achieved an accuracy rate of 71.08% on a dataset of 958 patients with non-small cell cancer treated with anti-tumor drugs. The proposed tool is potentially helpful for doctors in MDT tasks by vividly visualizing the large-scale complex clinical data and improving the MDT efficiency.

Indexed as

Carcinoma, Non-Small-Cell LungClinical Decision-MakingData VisualizationLung NeoplasmsAntineoplastic AgentsData AnalyticsHumansAntineoplastic AgentsClinical data visualization and analysisElectronic medical recordsLDAMDT

Identifiers

PMID41524897
PMCPMC12819497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.